BIONTECH SE (BNTX) NPV
Share news, reports & tips
13 January 2021 10:44
(Sharecast News) - Late stage clinical trial results for Johnson&Johnson's Covid-19 vaccine may be published in two weeks' time, possibly paving the way for the approval of another shot to...
11 January 2021 13:09
(Sharecast News) - US drug giant Pfizer and German partner BioNTech have boosted their target for producing Covid-19 vaccine doses in 2021 by more than half.
8 January 2021 12:27
(Sharecast News) - A new study showed that the Covid-19 vaccine developed by Pfizer and BioNTech might protect against variants of the novel coronavirus recently detected in the UK and South Africa.
5 January 2021 12:51
(Sharecast News) - Brussels is negotiating a deal with Pfizer and BioNTech to provide enough Covid-19 vaccine doses to inoculate as much as two-thirds of the bloc's population.
5 January 2021 12:22
(Sharecast News) - Reducing the dosage of currently approved Covid-19 vaccines could pose a public health risk, the Food and Drug Administration said.
15 December 2020 16:35
(Sharecast News) - US regulators confirmed the high efficacy and safety of Moderna's vaccine candidate in preventing Covid-19.
9 December 2020 09:15
(Sharecast News) - The European Medical Agency will not approve the Russian and Chinese vaccines for Covid-19 until Beijing and Moscow seek authorisation.
1 December 2020 12:22
(Sharecast News) - Pfizer and its German partner BioNTech have made their final submission to the European Medicines Agency for approval of their potential Covid-19 vaccine.
20 November 2020 12:41
(Sharecast News) - Pfizer and BioNTech have filed for Emergency Use Authorisation with America's drug regulator for their Covid-19 vaccine candidate, BNT162b2.
18 November 2020 12:09
(Sharecast News) - The Covid-19 vaccine candidate being developed by Pfizer and BioNTech has shown an elevated degree of efficacy in preventing Covid-19 among those aged 65 and over.
18 November 2020 11:33
(Sharecast News) - Pfizer has reached a key safety milestone for its Covid-19 vaccine candidate, having collected two months' worth of follow-on safety data from the volunteers dosed in its late stage...
16 November 2020 15:12
(Sharecast News) - Analysts at Bank of America hiked their target price for shares of US biotechnology outfit Moderna after interim clinical data from its Covid-19 vaccine trial met the high bar for...
Company announcements Announcements
No company announcements about BIONTECH SE NPV were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.